Your browser doesn't support javascript.
loading
Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis.
Levis, Brooke; Benedetti, Andrea; Ioannidis, John P A; Sun, Ying; Negeri, Zelalem; He, Chen; Wu, Yin; Krishnan, Ankur; Bhandari, Parash Mani; Neupane, Dipika; Imran, Mahrukh; Rice, Danielle B; Riehm, Kira E; Saadat, Nazanin; Azar, Marleine; Boruff, Jill; Cuijpers, Pim; Gilbody, Simon; Kloda, Lorie A; McMillan, Dean; Patten, Scott B; Shrier, Ian; Ziegelstein, Roy C; Alamri, Sultan H; Amtmann, Dagmar; Ayalon, Liat; Baradaran, Hamid R; Beraldi, Anna; Bernstein, Charles N; Bhana, Arvin; Bombardier, Charles H; Carter, Gregory; Chagas, Marcos H; Chibanda, Dixon; Clover, Kerrie; Conwell, Yeates; Diez-Quevedo, Crisanto; Fann, Jesse R; Fischer, Felix H; Gholizadeh, Leila; Gibson, Lorna J; Green, Eric P; Greeno, Catherine G; Hall, Brian J; Haroz, Emily E; Ismail, Khalida; Jetté, Nathalie; Khamseh, Mohammad E; Kwan, Yunxin; Lara, Maria Asunción.
Afiliação
  • Levis B; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Benedetti A; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Respiratory Epidemiology and Clinical Research Unit, McGill University Health Centre, Montréal, Québec, Canada; Department of Medicine, McGill University, Montréal, Québec, Canada.
  • Ioannidis JPA; Stanford Prevention Research Center, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University School of Medicine,
  • Sun Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Negeri Z; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • He C; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Wu Y; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Psychiatry, McGill University, Montréal, Québec, Canada.
  • Krishnan A; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Bhandari PM; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Neupane D; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Imran M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Rice DB; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Psychology, McGill University, Montréal, Québec, Canada.
  • Riehm KE; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Saadat N; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada.
  • Azar M; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
  • Boruff J; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montréal, Québec, Canada.
  • Cuijpers P; Department of Clinical, Neuro and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Gilbody S; Hull York Medical School and the Department of Health Sciences, University of York, Heslington, NY, UK.
  • Kloda LA; Library, Concordia University, Montréal, Québec, Canada.
  • McMillan D; Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
  • Patten SB; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada.
  • Shrier I; Lady Davis Institute for Medical Research, Jewish General Hospital, Montréal, Québec, Canada; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada; Department of Family Medicine, McGill University, Montréal, Québec, Canada.
  • Ziegelstein RC; Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Alamri SH; Faculty of Medicine, King Abdulaziz University, Jeddah, Makkah, Saudi Arabia.
  • Amtmann D; Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
  • Ayalon L; Louis and Gabi Weisfeld School of Social Work, Bar Ilan University, Ramat Gan, Israel.
  • Baradaran HR; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran; Ageing Clinical & Experimental Research Team, Institute of Applied Health Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, Scotl
  • Beraldi A; Kbo-Lech-Mangfall-Klinik Garmisch-Partenkirchen, Klinik für Psychiatrie, Psychotherapie & Psychosomatik, Lehrkrankenhaus der Technischen Universität München, Munich, Germany.
  • Bernstein CN; University of Manitoba IBD Clinical and Research Centre, Winnipeg, Manitoba, Canada; Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Bhana A; Centre for Rural Health, School of Nursing and Public Health, College of Health Sciences, University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa; Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.
  • Bombardier CH; Department of Rehabilitation Medicine, University of Washington, Seattle, WA, USA.
  • Carter G; Centre for Brain and Mental Health Research, University of Newcastle, New South Wales, Australia.
  • Chagas MH; Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.
  • Chibanda D; Department of Community Medicine, University of Zimbabwe, Harare, Zimbabwe.
  • Clover K; Centre for Brain and Mental Health Research, University of Newcastle, New South Wales, Australia.
  • Conwell Y; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA.
  • Diez-Quevedo C; Servei de Psiquiatria, Hospital Germans Trias i Pujol, Badalona, Spain; Departament de Psiquiatria i Medicina Legal, Universitat Autònoma de Barcelona, Badalona, Spain.
  • Fann JR; Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA.
  • Fischer FH; Department of Psychiatry, McGill University, Montréal, Québec, Canada; Department of Psychosomatic Medicine, Center for Internal Medicine and Dermatology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Gholizadeh L; Faculty of Health, University of Technology Sydney, Sydney, Australia.
  • Gibson LJ; Tropical Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Green EP; Duke Global Health Institute, Duke University, Durham, NC, USA.
  • Greeno CG; School of Social Work, University of Pittsburgh, Pittsburgh, PA, USA.
  • Hall BJ; Department of Psychology, Faculty of Social Sciences, Global and Community Mental Health Research Group, University of Macau, Macau Special Administrative Region, China; Department of Health, Behavior, and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Haroz EE; Center for American Indian Health, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
  • Ismail K; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neurosciences, King's College London Weston Education Centre, London, UK.
  • Jetté N; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Hotchkiss Brain Institute and O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Khamseh ME; Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.
  • Kwan Y; Department of Psychological Medicine, Tan Tock Seng Hospital, Singapore.
  • Lara MA; Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz. San Lorenzo Huipulco, Tlalpan, México D. F. Mexico.
J Clin Epidemiol ; 122: 115-128.e1, 2020 06.
Article em En | MEDLINE | ID: mdl-32105798
ABSTRACT

OBJECTIVES:

Depression symptom questionnaires are not for diagnostic classification. Patient Health Questionnaire-9 (PHQ-9) scores ≥10 are nonetheless often used to estimate depression prevalence. We compared PHQ-9 ≥10 prevalence to Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders (SCID) major depression prevalence and assessed whether an alternative PHQ-9 cutoff could more accurately estimate prevalence. STUDY DESIGN AND

SETTING:

Individual participant data meta-analysis of datasets comparing PHQ-9 scores to SCID major depression status.

RESULTS:

A total of 9,242 participants (1,389 SCID major depression cases) from 44 primary studies were included. Pooled PHQ-9 ≥10 prevalence was 24.6% (95% confidence interval [CI] 20.8%, 28.9%); pooled SCID major depression prevalence was 12.1% (95% CI 9.6%, 15.2%); and pooled difference was 11.9% (95% CI 9.3%, 14.6%). The mean study-level PHQ-9 ≥10 to SCID-based prevalence ratio was 2.5 times. PHQ-9 ≥14 and the PHQ-9 diagnostic algorithm provided prevalence closest to SCID major depression prevalence, but study-level prevalence differed from SCID-based prevalence by an average absolute difference of 4.8% for PHQ-9 ≥14 (95% prediction interval -13.6%, 14.5%) and 5.6% for the PHQ-9 diagnostic algorithm (95% prediction interval -16.4%, 15.0%).

CONCLUSION:

PHQ-9 ≥10 substantially overestimates depression prevalence. There is too much heterogeneity to correct statistically in individual studies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão Tipo de estudo: Guideline / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Depressão Tipo de estudo: Guideline / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies / Systematic_reviews Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article